Sportschosun Reporter Jang Jong-ho] As the use of obesity treatments rises rapidly worldwide, more people are achieving short ...

Retatrutide is being hailed as a “trillion-dollar” weight-loss breakthrough that also spares muscle. Is this really the holy ...

Nearly 90% of U.S. adults have at least one metabolic syndrome symptom linked to CKM syndrome - yet most have never heard of ...

Polyendocrine metabolic ovarian syndrome (PMOS) – formerly known as PCOS – affects up to 20pc of women, with risks from type ...

For years, spine surgery has been judged by what happens early. How long was the hospital stay? Were there complications? Did the patient need another operation? Did pain improve in the first year?

How water, land, mail, manpower and sugar are quietly failing at the same time — and why nobody is running the story as one story A levee doesn't fail all at once. It fails in five places nobody was ...

A review suggests that although obesity medications, such as GLP-1 drugs, can result in substantial weight loss, many obesity ...

Despite substantial weight loss, most obesity drugs such as Wegovy and Mounjaro do not meaningfully improve quality of life, ...

Obesity rates among U.S. adults and children rose sharply in recent years, and by 2023, 40% of adults and 20% of youth met ...

With the rise of Ozempic and Wegovy, I find myself asking a question I wish I were above asking: Is getting thinner the goal ...

Does informing people about their genetic risk of obesity help them change their habits and lose excess weight? A study, published in the journal Obesity Reviews by scientists including researchers ...

Higher socioeconomic status is not associated with equal reductions in rates of type 2 diabetes and obesity across all racial ...